[Federal Register Volume 72, Number 215 (Wednesday, November 7, 2007)]
[Notices]
[Page 62865]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-5561]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Industrial Macromolecular Crystallography 
Association

    Notice is hereby given that, on August 21, 2007, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301, et seq. (``the Act''), Industrial Macromolecular 
Crystallography Association (``IMCA'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing changes in its membership. The notifications were 
filed for the purpose of extending the Act's provisions limiting the 
recovery of antitrust plaintiffs to actual damages under specified 
circumstances. Specifically, Johnson & Johnson Pharmaceutical Research 
& Development, LLC, Raritan, NJ has been added as a party to this 
venture; 3-Dimensional Pharmaceuticals, Inc., Exton, PA has withdrawn 
as a party to this venture; and Pfizer Global Research and Development 
has changed its principal place of business to Groton, CT.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and IMCA intends to file additional 
written notifications disclosing all changes in membership.
    On October 23, 1990, IMCA filed its original notification pursuant 
to Section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to Section 6(b) of the Act on 
December 3, 1990 (55 FR 49952).
    The last notification was filed with the Department on November 17, 
2003. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on December 12, 2003 (68 FR 69422).

Patricia A. Brink,
Deputy Director of Operations, Antitrust Division.
[FR Doc. 07-5561 Filed 11-6-07; 8:45 am]
BILLING CODE 4410-11-M